drugset / Trial / NCT05599919

Nitric Oxide Nasal Spray (NONS) To Treat and Prevent the Exacerbation of Infection in Individuals With Mild COVID-19

NCT05599919

RandomizedParallel-groupQuadruple-blindPrevention

Summary

Primary: The primary objective of this study is to evaluate the efficacy of Nitric Oxide Nasal Spray combined with standard supportive care compared with standard supportive care alone in adult subjects with COVID-19 not requiring hospitalization Secondary: The secondary objective is to evaluate the safety and tolerability of Nitric Oxide Nasal Spray combined with standard supportive care compared with standard supportive care alone in adult subjects with COVID-19 not requiring hospitalization.

Timeline

Start
2021-11-01
Primary completion
2022-01-31
Completion
2022-02-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nitric Oxide Other / unclassified 0.11 ppm Intranasal

Indications